🕵️ Clene Inc. ($CLNN)
SEC insider & ownership activity, last 12 months · CIK 1822791 · every row links its SEC filing
Insider buy and sell values were withheld pending verification over the last 12 months. Alison Mosca trimmed 19.7% → 13.0%. No red-flag 8-Ks in the window.
Insider flow
1 buyer, value withheld pending verification (1 lots) · 1 seller, value withheld pending verification (62 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Ugwumba Chidozie | 0 | – | 62 | value withheld pending verification | May 12, 2026 |
| David J. Matlin | 1 | value withheld pending verification | 0 | – | Jan 13, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Alison Mosca | 13.0% | 13G | May 14, 2026 | filing ↗ | |
| VIVO Opportunity Fund Holdings, L.P. | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| VIVO Opportunity, LLC | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| VIVO Opportunity Cayman Fund, L.P. | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| VIVO Opportunity Cayman, LLC | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| Empery Asset Management, LP | 7.2% | 13G | Aug 4, 2026 | filing ↗ | |
| Ryan M. Lane | 7.2% | 13G | Aug 4, 2026 | filing ↗ | |
| David Lisonbee | 6.5% | 13G | Feb 14, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Symbiosis II LLC | $1.3M | May 11, 2026 | filing ↗ |
| Symbiosis II LLC | $270K | May 4, 2026 | filing ↗ |
| Symbiosis II LLC | $336K | Apr 28, 2026 | filing ↗ |
| Symbiosis II LLC | $670K | Apr 15, 2026 | filing ↗ |
| Symbiosis II LLC | $149K | Mar 24, 2026 | filing ↗ |
| Symbiosis II LLC | $477K | Mar 24, 2026 | filing ↗ |
| Symbiosis II LLC | $266K | Jan 29, 2026 | filing ↗ |
| Symbiosis II LLC | $3.8M | Dec 3, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Sep 15, 2026 | filing ↗ |
| Other events (8.01) | Sep 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 15, 2026 | filing ↗ |
| Earnings (2.02) | Aug 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 10, 2026 | filing ↗ |
| Other events (8.01) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Material agreement (1.01) | May 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 18, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 18, 2026 | filing ↗ |
| Material agreement (1.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Material agreement (1.01) | May 5, 2026 | filing ↗ |
| Other events (8.01) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 4, 2026 | filing ↗ |
| Other events (8.01) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 13, 2026 | filing ↗ |
| Earnings (2.02) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Other events (8.01) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |
| Other events (8.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 8, 2026 | filing ↗ |